Table 1.
FMDV and non‐target viral RNA used to determine analytical specificity of the FMDV RT‐iiPCR assay. Number of strains used for each serotype is given in parenthesis
| FMDV | ||
|---|---|---|
| Serotype A (16) | O/IRN/8/2005 | Serotype Asia (2) |
| A/EGY/3/2009 | O/KEN/62/2009 | Asia/NKR/2/2007 |
| A/ERI/2/1998 | O/KRG/2/2006 | Asia/VIT/8/2006 |
| A/ETH/12/2009 | O/MAI/15/2006 | Serotype SAT1 (4) |
| A/IRN/36/2010 | O/MAY/1/2005 | SAT1/BOT/12/2006 |
| A/IRQ/21/2009 | O/MAY/1/2010 | SAT1/ETH/3/2007 |
| A/KEN/7/2008 | O/NEP/3/2010 | SAT1/KEN/88/2010 |
| A/MAI/12/2006 | O/NIG/15/2009 | SAT1/ZAM/9/2008 |
| A/MAY/1/2007 | O/PAK/1/2010 | Serotype SAT2 (10) |
| A/NIG/38/2009 | O/SAU/1/2009 | SAT2/ETH/2/2007 |
| A/PAK/12/2010 | O/SAU/4/2005 | SAT2/KEN/122/2009 |
| A/SAU/24/1995 | O/SEN/8/2006 | SAT2/KEN/122/2009 |
| A/SUD/1/2006 | O/SKR/4/2010 | SAT2/KEN/122/2009 |
| A/TAI/5/2009 | O/SOM/1/2007 | SAT2/KEN/2/2007 |
| A/TUR/1/2008 | O/SUD/3/2008 | SAT2/MOZ/1/2010 |
| A/TUR/25/2007 | O/TAN/5/2009 | SAT2/SEN/27/2009 |
| A/VIT/8/2009 | O/UAE/2/2010 | SAT2/SUD/1/2008 |
| Serotype O (27) | O/UAE/9/2009 | SAT2/TAN/43/2009 |
| O/BUL/3/2011 | O/VIT/7/2008 | SAT2/ZAM/8/2008 |
| O/ECU/4/2010 | O/VIT/9/2005 | Serotype SAT3 (2) |
| O/EGY/8/2006 | O/ZAM/1/2010 | SAT3/SAR/1/2006 |
| O/ETH/39/2009 | Serotype C (2) | SAT3/UGA/10/1997 |
| O/HKN/1/2010 | C/ETH/6/2005 | |
| O/IRN/31/2010 | C/KEN/1/2004 | |
| Non‐targets | ||
| VSV‐IND | BPI‐3 SB | PRRSV YNL |
| VSV‐NJ | RPV Kabete O | PRCV Kiva |
| BTV‐11 | SVDV POR 1/2003 | PCV1 |
| EHDV Type 2 | SVDV UK27/72 | PCV2 B |
| BHV‐1 Type 1.1 Colorado #34 | CSFV Alfort 902 | ERAV |
| BVDV Type 2 24515 | VESV | |
| BCoV BRCV‐OK‐0514‐2 | ASFV Georgia 2007 | |
Codes for country of origins associated with FMD strains are based on abbreviations published by the FAO World Reference Laboratory for Foot‐and‐Mouth Disease (WRLFMD) ‐http://www.wrlfmd.org/fmd_serotyping/fmd_cntry_codes.htm. BOT: Botswana, BUL: Bulgaria, ECU: Ecuador, EGY: Egypt, ERI: Eritrea, ETH: Ethiopia, HKN: Hong Kong, IRN: Iran, IRQ: Iraq, KEN: Kenya, KRG: Kyrgyzstan, MAI: Mali, MAY: Malaysia, MOZ: Mozambique, NEP: Nepal, NIG: Niger, NKR: North Korea, PAK: Pakistan, POR: Portugal, SAR: Republic of South Africa, SAT: South African Territory, SAU: Saudi Arabia, SEN: Senegal, SKR: South Korea, SOM: Somalia, SUD: Sudan, TAI: Thailand, TAN: Tanzania, TUR: Turkey, UAE: United Arab Emirates, UK: United kingdom, UGA: Uganda, VIT: Vietnam, ZAM: Zambia. Non‐target viruses: ASFV: African swine fever virus, BCoV: bovine coronavirus, BHV‐1: bovine herpesvirus 1, BPI: bovine parainfluenza virus, BTV: bluetongue virus, BVDV: bovine viral diarrhoea virus, CSFV: classical swine fever virus, EHDV: epizootic haemorrhagic disease virus, ERAV (from NVSL): equine rhinitis A virus, PCV: porcine circovirus, PRCV: porcine respiratory coronavirus virus, PRRSV: porcine reproductive and respiratory syndrome virus, RPV: rinderpest virus, SVDV: swine vesicular disease virus, VESV: vesicular exanthema of swine virus, VSV‐IND: vesicular stomatitis virus – Indiana strain, VSV‐NJ: VSV – New Jersey strain.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.